Home›Cyp3a Inducers›Cyp3a Inducers + Imlunestrant

Does Cyp3a Inducers Interact with Imlunestrant?

Cyp3a Inducers and Imlunestrant have a major drug interaction according to U.S. FDA drug labeling data. Concomitant use decreases imlunestrant exposure, which may reduce effectiveness. Avoid concomitant use; if unavoidable, increase imlunestrant dosage. The mechanism involves imlunestrant is a cyp3a substrate; strong cyp3a inducers decrease its exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Imlunestrant Class
Estrogen Receptor Antagonist
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Cyp3a Inducers and Imlunestrant occurs because imlunestrant is a cyp3a substrate; strong cyp3a inducers decrease its exposure. Clinically, this means concomitant use decreases imlunestrant exposure, which may reduce effectiveness. avoid concomitant use; if unavoidable, increase imlunestrant dosage. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Cyp3a Inducers and your doctor is considering prescribing Imlunestrant (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Cyp3a Inducers+💊 Imlunestrant(Inluriyo)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
Estrogen Receptor Antagonist
Source
NLP:imlunestrant

What this means in plain English

Concomitant use decreases imlunestrant exposure, which may reduce effectiveness. Avoid concomitant use; if unavoidable, increase imlunestrant dosage.

What the FDA label says

"Imlunestrant is a CYP3A substrate; strong CYP3A inducers decrease its exposure"

📖 Source: NLP:imlunestrant

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Cyp3a Inducers and Imlunestrant against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.